These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7717176

  • 1. Activation of endothelial guanylate cyclase inhibits cellular reactivity.
    Heller R, Bussolino F, Ghigo D, Pescarmona GP, Calvino R, Gasco A, Till U, Bosia A.
    Agents Actions Suppl; 1995; 45():177-81. PubMed ID: 7717176
    [Abstract] [Full Text] [Related]

  • 2. S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.
    Heller R, Bussolino F, Calvino R, Ghigo D, Alessio P, Todde R, Fruttero R, Pescarmona G, Gasco A, Till U.
    Agents Actions; 1993 Nov; 40(3-4):157-65. PubMed ID: 7517616
    [Abstract] [Full Text] [Related]

  • 3. Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells.
    Heller R, Bussolino F, Ghigo D, Garbarino G, Pescarmona G, Till U, Bosia A.
    Biochem Pharmacol; 1992 Jul 22; 44(2):223-9. PubMed ID: 1322663
    [Abstract] [Full Text] [Related]

  • 4. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A, Busse R, Bassenge E.
    Z Kardiol; 1989 Jul 22; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B, Grewe R, Loeschke K, Gerzer R.
    Pathol Biol (Paris); 1987 Feb 22; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [Abstract] [Full Text] [Related]

  • 6. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
    Mülsch A, Busse R, Bassenge E.
    Eur J Pharmacol; 1988 Dec 13; 158(3):191-8. PubMed ID: 2908105
    [Abstract] [Full Text] [Related]

  • 7. [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs].
    Piatakova NV, Severina IS.
    Biomed Khim; 2012 Dec 13; 58(1):32-42. PubMed ID: 22642150
    [Abstract] [Full Text] [Related]

  • 8. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance.
    Mülsch A, Busse R, Winter I, Bassenge E.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May 13; 339(5):568-74. PubMed ID: 2570362
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP.
    Heller R, Polack T, Gräbner R, Till U.
    Atherosclerosis; 1999 May 13; 144(1):49-57. PubMed ID: 10381277
    [Abstract] [Full Text] [Related]

  • 10. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation.
    Gong GX, Weiss HR, Tse J, Scholz PM.
    Eur J Pharmacol; 1998 Mar 05; 344(2-3):299-305. PubMed ID: 9600666
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction.
    Teunissen CE, Steinbusch HW, Markerink-van Ittersum M, De Bruijn C, Axer H, De Vente J.
    Brain Res Dev Brain Res; 2000 Dec 29; 125(1-2):99-115. PubMed ID: 11154766
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
    Gerzer R, Karrenbrock B, Siess W, Heim JM.
    Thromb Res; 1988 Oct 01; 52(1):11-21. PubMed ID: 2904706
    [Abstract] [Full Text] [Related]

  • 16. Activation by nitric oxide of guanylate cyclase in endothelial cells from brain capillaries.
    Marsault R, Frelin C.
    J Neurochem; 1992 Sep 01; 59(3):942-5. PubMed ID: 1353791
    [Abstract] [Full Text] [Related]

  • 17. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan 01; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 18. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
    Cardoso MH, Morganti RP, Lilla S, Murad F, De Nucci G, Antunes E, Marcondes S.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):229-34. PubMed ID: 19895807
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the vasodilator action of SIN-1 by the endothelium.
    Busse R, Pohl U, Mülsch A, Bassenge E.
    J Cardiovasc Pharmacol; 1989 Feb 10; 14 Suppl 11():S81-5. PubMed ID: 2484706
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.